U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H17N3O3
Molecular Weight 287.3138
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GABAZINE FREE BASE

SMILES

COC1=CC=C(C=C1)C2=NN(CCCC(O)=O)C(=N)C=C2

InChI

InChIKey=ACVGNKYJVGNLIL-UHFFFAOYSA-N
InChI=1S/C15H17N3O3/c1-21-12-6-4-11(5-7-12)13-8-9-14(16)18(17-13)10-2-3-15(19)20/h4-9,16H,2-3,10H2,1H3,(H,19,20)

HIDE SMILES / InChI

Molecular Formula C15H17N3O3
Molecular Weight 287.3138
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Gabazine (SR-95531) is a selective GABAA receptors antagonist, which does not have any role in medicine, but is used in scientific experiments as the allosteric inhibitor of channel opening for the GABAA receptor.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Agonist-, antagonist-, and benzodiazepine-induced structural changes in the alpha1 Met113-Leu132 region of the GABAA receptor.
2007 Feb
GluK2-mediated excitability within the superficial layers of the entorhinal cortex.
2009
Novel mGluR- and CB1R-independent suppression of GABA release caused by a contaminant of the group I metabotropic glutamate receptor agonist, DHPG.
2009 Jul 1
An approach for reliably investigating hippocampal sharp wave-ripples in vitro.
2009 Sep 7
Dopamine inhibition of glycine release in the rat trigeminal nucleus pars caudalis: possible involvement of trace amine receptors.
2010 Sep
Patents

Patents

Sample Use Guides

Neonatal and 21-day-old (P21) rats: P3 rat pups were anaesthetized and a syringe containing 0.5 μl of 0.9 % saline with 2.2 μCi of 3[H]Gabazine was inserted intrathecally. The compound was injected and 10min post injection the animals were terminally anaesthetized with sodium pentobarbitone. Injections of 3H-gabazine in the L4-L5 region at P3 confirmed that gabazine binding was restricted to the lumbar spinal cord. The effects of spinalization were consistent with gabazine facilitation of ventral root potentials observed in isolated neonatal spinal cord.
Route of Administration: Other
Gabazine totally blocked evoked inhibitory postsynaptic currents (IPSCs) in CA3 pyramidal cells. The application of guanidinoethanesulfonic acid, an uptake inhibitor of beta-alanine and taurine, induced strychnine-sensitive chloride current in the presence of gabazine. To determine whether glycine receptors, which are expressed most strongly on CA3 pyramidal cells, are involved in synaptic transmission, it was characterized the pharmacological profile of the receptors mediating IPSCs evoked by brief extracellular stimulation (100 μs, single current pulse up to 30 μA) in the stratum radiatum of the CA3 region in the presence of CNQX (40 μm), CPP (40 μm) and CGP 62349 (5 μm). First, the sensitivity of the IPSC to GABAA receptor blockade by gabazine was tested. Evoked IPSCs and responses to GABA puffs were alternately induced. The degree of GABAA receptor blockade was monitored by examining the effect of gabazine on responses induced by GABA puffs, whose peak amplitudes were adjusted to match those of the alternately evoked IPSCs. Bath application of gabazine (10 μm) completely blocked the IPSC and inhibited the GABA-induced currents by 98.7 ± 0.3 % (n = 7). Application of gabazine also abolished spontaneous IPSCs. The incomplete blockade of responses to exogenous GABA by the competitive antagonist gabazine probably reflects the prolonged presence of GABA resulting from the puff applications, which may saturate GABA transporters, since even with the addition of gabazine to the GABA application pipette, GABA-induced currents could not be blocked completely.
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:52:37 GMT 2023
Edited
by admin
on Sat Dec 16 08:52:37 GMT 2023
Record UNII
L45297DIU1
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GABAZINE FREE BASE
Common Name English
1,6-DIHYDRO-6-IMINO-3-(4-METHOXYPHENYL)-1-PYRIDAZINEBUTANOIC ACID
Systematic Name English
4-(6-IMINO-3-(4-METHOXYPHENYL)-1(6H)-PYRIDAZINYL)BUTANOIC ACID
Systematic Name English
1(6H)-PYRIDAZINEBUTANOIC ACID, 6-IMINO-3-(4-METHOXYPHENYL)-
Systematic Name English
4-(6-IMINO-3-(4-METHOXYPHENYL)PYRIDAZIN-1(6H)-YL)BUTANOIC ACID
Systematic Name English
2-(3-CARBOXYPROPYL)-3-AMINO-6-(4-METHOXYPHENYL)PYRIDAZINIUM
Systematic Name English
SR95531
Code English
J331.170H
Code English
4-(6-IMINO-3-(4-METHOXYPHENYL)PYRIDAZIN-1-YL)BUTANOIC ACID
Systematic Name English
6-IMINO-3-(4-METHOXYPHENYL)-1(6H)-PYRIDAZINEBUTANOIC ACID
Systematic Name English
C13796
Code English
Code System Code Type Description
FDA UNII
L45297DIU1
Created by admin on Sat Dec 16 08:52:38 GMT 2023 , Edited by admin on Sat Dec 16 08:52:38 GMT 2023
PRIMARY
CAS
105538-73-6
Created by admin on Sat Dec 16 08:52:38 GMT 2023 , Edited by admin on Sat Dec 16 08:52:38 GMT 2023
PRIMARY
PUBCHEM
107896
Created by admin on Sat Dec 16 08:52:38 GMT 2023 , Edited by admin on Sat Dec 16 08:52:38 GMT 2023
PRIMARY
EPA CompTox
DTXSID20276043
Created by admin on Sat Dec 16 08:52:38 GMT 2023 , Edited by admin on Sat Dec 16 08:52:38 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT